Sherwin-Williams delivered strong Q1 results with sales and margins improving year-over-year. However, the revised full-year guidance indicating flat to slightly declining sales due to COVID-19 uncertainties may weigh on investor sentiment in the short term. Despite managementâ€™s confidence and strategic measures, the tempered outlook is likely to exert downward pressure on the stock.

[-1]